Top Tweets for #namenabled
Thank you to all our employees, patients and healthcare providers for all that you do to advance the science of #NAMenabled cell therapies so that patients may live longer better lives. Wishing you and your family happy holidays and best wishes for the new year.
As #ESMO I/O comes to an end, Gamida Cell is advancing its unique curative approach with #NAMenabled immuno cell therapy candidates as a potential new treatment for patients with hematologic and solid tumor cancers.
#GamidaCell, the global leader in the development of #NAMenabled cell therapies, will present at the upcoming #EvercoreHealthConX Investor Conference on Thursday, December 1, 2022.
Learn more https://t.co/6MtZ7AcE1p
#GamidaCell presents #GDA501, a #NAMenabled genetically modified NK Cell candidate, demonstrating promising antitumor activity against HER2+ cancers at the #SITC 37th Annual Meeting.
Learn More: https://t.co/MYdcpvg7Py
#GamidaCell, the leader in the development of #NAMenabled cell therapies for patients with hematologic and solid cancers and other serious diseases, is thrilled to deliver its corporate presentation to industry leaders tomorrow @alliancerm
Press Release https://t.co/GZsi1MhPbi
As #ESMO2022 ends, Gamida Cell continues to advance its unique curative approach with #NAMenabled cell therapy candidates as a potential new treatment for patients with hematologic and solid tumor cancers.
https://t.co/qqx09ZzK1X
#StemCellTherapy
#NKCellTherapy
#BloodCancers
Gamida Cell celebrates #SU2C Day. We are harnessing the power of our proprietary #NAMenabled technology to create innovative cell therapies with the potential to redefine standards of care for patients with cancers.
Learn more: https://t.co/7EM0Iudbir
September raises awareness of blood cancers and the critical need for better and safer therapies. #GamidaCell is developing genetically modified #NAMenabled NK cells as potential therapies to benefit patients with blood cancers.
Learn More: https://t.co/5yT5s2mCxw
#WallStreetTranscript interviews #GamidaCell CEO, Julian Adams, Ph.D., to learn more about near and long term opportunities for success with #NAMenabled cell therapies. https://t.co/vVcyj32hX4
#StemCellTherapy
#Omidubicel
#NKCellTherapy
#GDA201
Gamida Cell announced the first patient dosed in Phase 1/2 study of #NAMenabled NK cell therapy candidate #GDA201 for treatment of patients with #follicularlymphoma and #diffuselargeBcelllymphoma.
https://t.co/uLC7RDPAGq
#Committedtocures
#NKCellTherapy
#Lymphoma
#LRF
Gamida Cell is developing next-generation genetically modified #NAMenabled NK cells - sourced from cord blood - as potential cancer-killing cell therapies to benefit patients with hematologic and solid tumor cancers.
https://t.co/5yT5s2mCxw
#CordBloodMonth
Clinical trials continue to demonstrate the benefits of cord blood and diseases it can help manage and cure. Gamida Cell is advancing multiple #NAMenabled cell therapies derived from cord blood as a curative approach for cancer patients. https://t.co/5yT5s2mCxw
#CordBloodMonth
Gamida Cell is harnessing the power of its proprietary #NAMenabled technology to create cell therapies with the potential to redefine standards of care for patients with cancers and other serious diseases. https://t.co/nAKOuwTa8u
#StemCellTherapy
#NKCellTherapy
#BloodCancers
During #CordBloodAwarenessMonth, Gamida Cell is educating people on its proprietary #NAMenabled technology that creates innovative cell therapies from cord blood as a potential curative approach for cancer patients. https://t.co/fXshB5tLPr
#StemCellTherapy
#NKCellTherapy
Oral presentation on our #NAMenabled NK cell therapy candidate #GDA201 at #AACRMalignantLymphoma supports clinical findings that #NAMtechnology enhances number and functionality of immune cells for improved patient outcomes. https://t.co/tZysXWAib7
#NKCellTherapy
#Lymphoma
#LRF
#AACRMalignantLymphoma: Gamida Cell's Phase 1/2 study, now open for enrollment, is evaluating #NAMenabled NK cell therapy candidate #GDA201 as new treatment option for patients with #follicularlyphoma and #diffuselargBcelllymphoma. https://t.co/tmibk8fO1t
#NKCellTherapy
As #EHA2022 ends, Gamida Cell continues to advance its unique curative approach with #NAMenabled cell therapy candidates as a potential new treatment for patients with hematologic and solid tumor cancers. https://t.co/dAmSq1l24z
#StemCellTherapy
#NKCellTherapy
#BloodCancers
Gamida Cell, the leader in the development of #NAMenabled cell therapy candidates, will participate in Fire side chat @JmpSecurities Lifesciences Conference on June 16 @ 2PMET. https://t.co/M8sHzMEZQw
#StemCellTherapy
#NKCellTherapy
#ASCO2022
#Hematology
#BloodCancers
#ASCO2022 inspires all of us to do more. Gamida Cell is advancing a unique curative approach with #NAMenabled cell therapy candidates as a potential new treatment for patients with hematologic and solid tumor cancers. https://t.co/dAmSq1l24z
#StemCellTherapy
#NKCellTherapy
Gamida Cell, the leader in the development of #NAMenabled cell therapy candidates, will present @Jefferies 2022 Global Healthcare Conference on June 8 @ 11 AM ET.
https://t.co/TxTju3u6B6
#GamidaStemCellTherapy
#NKCellTherapy
#ASCO2022
#Hematology
#Lymphoma
#LRF
#LLS
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers